Pre-workout Supplement Versus Caffeine on Energy Expenditure.
Effects of a Multi-ingredient Pre-workout Supplement Versus Caffeine on Energy Expenditure and Feelings of Fatigue During Low-intensity Treadmill Exercise in College-aged Males.
1 other identifier
interventional
12
1 country
1
Brief Summary
The primary purpose of this study was to examine the acute effects of a multi-ingredient pre-workout supplement versus an ergogenic dose of caffeine (6 mg/kg) on energy expenditure during low-intensity exercise. The effects of these substances on substrate utilization, gas exchange, and psychological factors were also investigated. Twelve males (mean ± SD: age = 22.8 ± 2.4 years) completed three bouts of 60-min of treadmill exercise at 4.8-6.4 km/hr on separate days after consuming a pre-workout supplement, 6 mg/kg of caffeine, or placebo in a randomized fashion. The pre-workout and caffeine supplements resulted in significantly greater energy expenditure (p \< 0.001, p = 0.006, respectively), VO2 (p \< 0.001, p = 0.007, respectively), VCO2 (p = 0.006, p = 0.049, respectively), and VE (p \< 0.001, p = 0.007, respectively), but not rates of fat or carbohydrate oxidation or respiratory exchange ratio compared to placebo (collapsed across condition). In addition, the pre-workout supplement increased feelings of alertness (p = 0.015) and focus (p = 0.005) 30-minutes post-ingestion and decreased feelings of fatigue (p = 0.014) during exercise compared to placebo (collapsed across condition). Thus, the pre-workout supplement increased energy expenditure and measures of gas exchange to the same extent as 6 mg/kg of caffeine with concomitant increased feelings of alertness and focus and decreased feelings of fatigue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Sep 2019
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
August 26, 2020
CompletedFirst Posted
Study publicly available on registry
September 4, 2020
CompletedSeptember 4, 2020
August 1, 2020
4 months
August 26, 2020
August 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Energy expenditure
Measurement of caloric expenditure via gas exchange
Measured continuously during 60 minutes of exercise for all three supplement conditions
Secondary Outcomes (9)
Oxygen consumption
Measured continuously during 60 minutes of exercise for all three supplement conditions
Carbon dioxide production
Measured continuously during 60 minutes of exercise for all three supplement conditions
Minute ventilation
Measured continuously during 60 minutes of exercise for all three supplement conditions
Feelings of fatigue
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
Feelings of energy
Baseline, 30-minutes post-ingestion of supplement, and at the 30-minute time point of exercise for all three supplement conditions
- +4 more secondary outcomes
Study Arms (3)
Pre-Workout Condition
EXPERIMENTALThis condition consisted of the ingestion of one serving of the pre-workout supplement.
Caffeine Condition
EXPERIMENTALThis condition consisted of the ingestion of 6 mg of caffeine per kg of body mass.
Placebo condition
PLACEBO COMPARATORThis condition consisted of the ingestion of a placebo.
Interventions
ENGN Shred is a multi-ingredient pre-workout supplement.
Non-caloric Crystal Light matched for the pre-workout in terms of flavor and consistency.
Eligibility Criteria
You may qualify if:
- Male
You may not qualify if:
- history of medical or surgical events, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders;
- use of any medications
- use of nutritional supplements
- habitual use of caffeine (≥1 caffeinated beverage per day)
- participation in another clinical trial or investigation of another investigational product within 30 days prior to screening/enrollment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Exercise Physiology Laboratory
DeKalb, Illinois, 60115, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Clayton L Camic, PhD
Northern Illinois University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 26, 2020
First Posted
September 4, 2020
Study Start
September 1, 2019
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
September 4, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share